Black Diamond Therapeutics
Sanna Belorusets, CPA, MBA, is an accomplished finance professional with extensive experience in the biotech and pharmaceutical sectors. Currently serving as VP of Finance at Black Diamond Therapeutics, Sanna has held several key positions, including Senior Director of Finance at Mersana Therapeutics, Director of SEC Reporting at Enanta Pharmaceuticals, Controller at Permabit Technology Corporation, and Manager of Corporate Accounting at Biogen Idec. Sanna holds an MBA in Strategy and Business Policy from Boston University and a Bachelor of Science in Accountancy from Bentley University.
Black Diamond Therapeutics
3 followers
Black Diamond Therapeutics is a leading venture-backed biotechnology company focused on the discovery and development of precision medicines for cancer that are directed against a novel class of allosteric mutant oncogenes.